Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brexit

Set Alert for Brexit

Pharma Breathes Sigh Of Relief Over Brexit Deal

The ABPI and EFPIA give a cautious welcome, but are pleased it means "ongoing collaboration in key areas including scientific research and cooperation in areas like medicines safety."

Brexit Business Strategies Deals

Brexit Finally Here But Uncertainty Not Over For Biopharma

A free trade deal needs to be negotiated in record time and UK life sciences must face up to diverging from the EU.

Europe United Kingdom Brexit

Latest From Brexit

Fit For The Future: Industry Gets Involved As UK Medtech And Digital Health Care Regulation Reaches Turning Point

The MHRA is in listening mode as it gathers feedback to shape the UKCA marking for medical devices. That, and how the agency precisely will oversee UK device regulation in the future, are front of mind for industry.

United Kingdom Regulation

UK Device Regulatory System Off To Good Start Under ‘Supportive’ MHRA

The UK’s new medical device registration system, one element of the post-Brexit transition being overseen by the MHRA, is going more or less to plan in the early stages of the standstill period.

United Kingdom Regulation

BTG SP Makes A Virtue Of Manufacturing And Supply Discipline Despite COVID

Manufacturing and supply chain resilience ensured that BTG Specialty Pharma met its sales target in the COVID-affected 2020. Its president, Anthony Higham, explained how this was possible while the company busily  ̶  and quietly – sought new ownership, and all under the shadow of Brexit.

Business Strategies Innovation

How To Navigate Northern Ireland's Complex Regulatory Landscape

A TOPRA webinar gave UK-based pharma firms an idea of the complexities and uncertainties they will need to deal with when placing medicines on the market in different parts of the UK.

United Kingdom Brexit

EU OTC Batch Testing Will Continue To Be Accepted In UK, For Now

Recognition of EU/EEA batch testing of imported medicines by UK will not be ending on 1 January 2023, and companies will be given two years notice if anything changes, says MHRA.

United Kingdom Health

UK Extends Recognition Of EU Batch Testing Pending Review

Having to set up duplicate testing facilities in the EU and the UK is an expensive business, so pharmaceutical companies are relieved that the UK is giving them some extra breathing space.

Europe United Kingdom

Scrip Asks…What Does 2021 Hold For Biopharma? Part 5: Business Environment And Strategy

A strong year is predicted for biopharma business with investment and deal making set to continue apace. Executives across industry share their forecasts for the year ahead.

Artificial Intelligence Brexit

EU Notified Bodies Advise Manufacturers To Think Hard About Regulatory Strategy Timings

Waiting until the grace period expires before making a product application under the EU MDR or IVDR is a gambit that could easily misfire, TEAM-NB warns.

EU Compliance

How The UK Self-Care Industry Coped With COVID-19 And Brexit in 2020

PAGB CEO Michelle Riddalls tells HBW Insight what it was like to lead the UK consumer health industry during 2020 in the middle of Brexit and COVID-19.

United Kingdom Health
See All
UsernamePublicRestriction

Register